DK403188A - Piperazinylpurin og fremgangsmaade til fremstilling deraf - Google Patents
Piperazinylpurin og fremgangsmaade til fremstilling derafInfo
- Publication number
- DK403188A DK403188A DK403188A DK403188A DK403188A DK 403188 A DK403188 A DK 403188A DK 403188 A DK403188 A DK 403188A DK 403188 A DK403188 A DK 403188A DK 403188 A DK403188 A DK 403188A
- Authority
- DK
- Denmark
- Prior art keywords
- piperazinylpurin
- procedures
- preparing
- compounds
- disclosed
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- XHMOVCSOULHBDU-UHFFFAOYSA-N 2-piperazin-1-yl-7h-purine Chemical compound C1CNCCN1C1=NC=C(NC=N2)C2=N1 XHMOVCSOULHBDU-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- FFNVVVLETZYYJN-UHFFFAOYSA-N 6-piperazin-1-yl-7h-purine Chemical compound C1CNCCN1C1=NC=NC2=C1NC=N2 FFNVVVLETZYYJN-UHFFFAOYSA-N 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7536287A | 1987-07-20 | 1987-07-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK403188D0 DK403188D0 (da) | 1988-07-19 |
| DK403188A true DK403188A (da) | 1989-03-30 |
Family
ID=22125206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK403188A DK403188A (da) | 1987-07-20 | 1988-07-19 | Piperazinylpurin og fremgangsmaade til fremstilling deraf |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0300726B1 (no) |
| JP (1) | JP2562181B2 (no) |
| KR (1) | KR890002155A (no) |
| AT (1) | ATE94877T1 (no) |
| AU (1) | AU601862B2 (no) |
| CA (1) | CA1341043C (no) |
| DE (1) | DE3884304T2 (no) |
| DK (1) | DK403188A (no) |
| ES (1) | ES2058291T3 (no) |
| FI (1) | FI883423A (no) |
| HU (1) | HU199144B (no) |
| IL (1) | IL87149A (no) |
| NO (1) | NO167203C (no) |
| NZ (1) | NZ225447A (no) |
| PT (1) | PT88029B (no) |
| YU (1) | YU46761B (no) |
| ZA (1) | ZA885242B (no) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86007A0 (en) * | 1987-04-09 | 1988-09-30 | Wellcome Found | 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them |
| GB8716313D0 (en) * | 1987-07-10 | 1987-08-19 | Janssen Pharmaceutica Nv | 2-(heterocyclylalkyl)imidazopyridines |
| GB8922076D0 (en) * | 1989-09-28 | 1989-11-15 | Beecham Group Plc | Novel process |
| DK150591D0 (da) * | 1991-08-26 | 1991-08-26 | Novo Nordisk As | Kemisk forbindelse |
| US5583137A (en) * | 1992-02-19 | 1996-12-10 | Pfizer Inc. | Heterocyclic compounds for enhancing antitumor activity |
| US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
| AU3053999A (en) | 1998-03-31 | 1999-10-25 | Kyowa Hakko Kogyo Co. Ltd. | Nitrogenous heterocyclic compounds |
| US7544675B2 (en) | 2002-04-18 | 2009-06-09 | Ucb, S.A. | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| AU2003302657B8 (en) | 2002-12-04 | 2009-12-03 | Eisai R&D Management Co., Ltd. | Fused 1,3-dihydroimidazole ring compounds |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7776893B2 (en) | 2003-09-05 | 2010-08-17 | Nycomed Gmbh | Use of PDE4 inhibitors for the treatment of diabetes mellitus |
| WO2005063744A2 (en) | 2003-12-22 | 2005-07-14 | K.U. Leuven Research & Development | IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| WO2006009734A1 (en) | 2004-06-17 | 2006-01-26 | Wyeth | Gonadotropin releasing hormone receptor antagonists |
| US7714130B2 (en) | 2004-06-17 | 2010-05-11 | Wyeth | Processes for preparing gonadotropin releasing hormone receptor antagonists |
| DE602005013580D1 (de) | 2004-12-21 | 2009-05-07 | Leuven K U Res & Dev | Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) * | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| AU2006222060B2 (en) | 2005-03-08 | 2011-09-01 | Takeda Gmbh | Roflumilast for the treatment of diabetes mellitus |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| AR061969A1 (es) | 2006-07-07 | 2008-08-10 | Gilead Sciences Inc | Derivados halogenados de imidazo-piridino, metodo de preparacion, composiciones farmaceuticas que los contienen y usos como agentes anti vhc |
| US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
| CN102089308A (zh) * | 2008-07-07 | 2011-06-08 | 艾科睿控股公司 | Pi3k亚型选择性抑制剂 |
| UA104010C2 (en) | 2008-12-18 | 2013-12-25 | Эли Лилли Энд Компани | Purine compounds |
| US8901132B2 (en) * | 2009-03-13 | 2014-12-02 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Thiazolopyrimidine modulators as immunosuppressive agents |
| AR080711A1 (es) | 2010-03-31 | 2012-05-02 | Lilly Co Eli | Compuesto de piperazin-purina composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento o prevencion del dolor |
| BR112012024587A2 (pt) | 2010-03-31 | 2016-05-31 | Lilly Co Eli | compostos de purina usados como agonistas de cb2 |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2828346C (en) | 2011-03-01 | 2021-01-26 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
| EP3718557A3 (en) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| LT2991987T (lt) * | 2013-05-02 | 2018-08-10 | F. Hoffmann-La Roche Ag | Purino dariniai kaip cb2 receptorių antagonistai |
| EA201592263A1 (ru) | 2013-06-05 | 2016-05-31 | Синерджи Фармасьютикалз, Инк. | Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования |
| CA2920856A1 (en) | 2013-08-09 | 2015-02-12 | Ardelyx, Inc. | Ph modulating compounds for inhibiting gastrointestinal phosphate uptake |
| CN104497085B (zh) * | 2015-01-16 | 2017-05-24 | 华东理工大学 | 腺苷衍生物及其用途 |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1115260B (de) * | 1957-02-27 | 1961-10-19 | Thomae Gmbh Dr K | Verfahren zur Herstellung von Purinderivaten |
| GB1186504A (en) * | 1966-10-15 | 1970-04-02 | Fisons Pest Control Ltd | Substituted Heterocyclic Compounds |
| JPS60260579A (ja) * | 1984-01-13 | 1985-12-23 | Yoshitomi Pharmaceut Ind Ltd | プリン誘導体 |
| JPS6210085A (ja) * | 1985-07-05 | 1987-01-19 | Yoshitomi Pharmaceut Ind Ltd | トリフルオロメチルプリン誘導体 |
-
1988
- 1988-07-18 IL IL8714988A patent/IL87149A/xx unknown
- 1988-07-18 NZ NZ225447A patent/NZ225447A/en unknown
- 1988-07-19 EP EP88306584A patent/EP0300726B1/en not_active Expired - Lifetime
- 1988-07-19 DK DK403188A patent/DK403188A/da not_active Application Discontinuation
- 1988-07-19 ES ES88306584T patent/ES2058291T3/es not_active Expired - Lifetime
- 1988-07-19 HU HU883774A patent/HU199144B/hu not_active IP Right Cessation
- 1988-07-19 AU AU19230/88A patent/AU601862B2/en not_active Ceased
- 1988-07-19 CA CA000572450A patent/CA1341043C/en not_active Expired - Fee Related
- 1988-07-19 AT AT88306584T patent/ATE94877T1/de not_active IP Right Cessation
- 1988-07-19 NO NO883204A patent/NO167203C/no unknown
- 1988-07-19 DE DE88306584T patent/DE3884304T2/de not_active Expired - Fee Related
- 1988-07-19 PT PT88029A patent/PT88029B/pt not_active IP Right Cessation
- 1988-07-19 FI FI883423A patent/FI883423A/fi not_active Application Discontinuation
- 1988-07-20 JP JP63179325A patent/JP2562181B2/ja not_active Expired - Fee Related
- 1988-07-20 YU YU141088A patent/YU46761B/sh unknown
- 1988-07-20 KR KR1019880009044A patent/KR890002155A/ko not_active Application Discontinuation
- 1988-07-20 ZA ZA885242A patent/ZA885242B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2562181B2 (ja) | 1996-12-11 |
| DE3884304T2 (de) | 1994-03-24 |
| DK403188D0 (da) | 1988-07-19 |
| ZA885242B (en) | 1989-03-29 |
| JPH01104074A (ja) | 1989-04-21 |
| KR890002155A (ko) | 1989-04-08 |
| HU199144B (en) | 1990-01-29 |
| EP0300726B1 (en) | 1993-09-22 |
| IL87149A0 (en) | 1988-12-30 |
| NO167203B (no) | 1991-07-08 |
| NO883204D0 (no) | 1988-07-19 |
| PT88029A (pt) | 1989-06-30 |
| AU601862B2 (en) | 1990-09-20 |
| PT88029B (pt) | 1995-03-01 |
| ES2058291T3 (es) | 1994-11-01 |
| YU46761B (sh) | 1994-05-10 |
| IL87149A (en) | 1994-05-30 |
| NO883204L (no) | 1989-01-23 |
| NZ225447A (en) | 1991-12-23 |
| HUT47575A (en) | 1989-03-28 |
| ATE94877T1 (de) | 1993-10-15 |
| YU141088A (en) | 1990-10-31 |
| CA1341043C (en) | 2000-07-04 |
| AU1923088A (en) | 1989-01-27 |
| NO167203C (no) | 1991-10-16 |
| DE3884304D1 (de) | 1993-10-28 |
| FI883423A0 (fi) | 1988-07-19 |
| EP0300726A1 (en) | 1989-01-25 |
| FI883423A (fi) | 1989-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK403188A (da) | Piperazinylpurin og fremgangsmaade til fremstilling deraf | |
| DE3466227D1 (en) | Insulin derivatives, processes for their preparation, their use and pharmaceutical compositions for the treatment of diabetes mellitus | |
| HUP0300642A2 (hu) | Antidiabetikus készítmény és alkalmazása | |
| HUP0002373A2 (hu) | Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények | |
| NO875299D0 (no) | Insulinpreparat for ikke-paranteral administrasjon. | |
| DK280884A (da) | Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling | |
| NO890259D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| WO2001032157A3 (en) | Pharmaceutical composition comprising a combination of metformin and glibenclamide | |
| DK281184D0 (da) | Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling | |
| DK124288A (da) | Praeparat med langvarig frigivelse til parenteral indgivelse | |
| GR3003402T3 (en) | Vanadium-peroxide compositions as insulin mimickers | |
| IT1226727B (it) | Farmaci precursori della dopamina. | |
| PH25587A (en) | Mixed crystals of insulin, insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals,, theu use thereof for the treatment of diabetes mellitus | |
| HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
| DK440288A (da) | Anvendelse af eicosapentaensyre og/eller docosahexaensyre til fremstilling af midler til behandling af diabetes mellitus | |
| DK391089D0 (da) | Thiazolforbindelser og fremgangsmaader til fremstilling deraf | |
| UA8036A1 (uk) | Спосіб одержання похідних тіазолу або їх кислотно-аддітивних солей | |
| DK226688D0 (da) | Middel til behandling og forebyggelse af asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |